AJPB staff

Top news of the day from across the health care landscape.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

CDC officials said this year’s influenza season may be peaking, but it will likely take several more weeks before activity slows down.

Plecanatide has already been approved for the treatment of chronic idiopathic constipation.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

Angiotensin II injection approved for intravenous infusion to treat dangerously low blood pressure in adults with septic or other distributive shock.

Top articles of the week from The American Journal of Pharmacy Benefits.

Ertugliflozin (Steglatro) is also approved as part of 2 fixed-dose combinations.

Top articles of the week from The American Journal of Pharmacy Benefits.

Cariprazine is an oral atypical antipsychotic currently approved for the acute treatment of adults with manic or mixed episodes associated with bipolar I disorder.

Some health care antiseptics currently on the market won’t be affected by FDA decision.

Top articles of the week from The American Journal of Pharmacy Benefits.

Sildenafil tablets are a phosphodiesterase-5 inhibitor indicated for the treatment of erectile dysfunction.

Glycopyrrolate inhalation solution is the first nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

Cariprazine is a once-daily atypical antipsychotic for patients with bipolar I disorder and schizophrenia.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

Ferric citrate was originally approved for the control of serum phosphorus levels in patients with chronic kidney disease who require dialysis.

A look at last week's top stories in the world of pharmacy.

Xarelto reduces the continued risk for recurrent venous thromboembolism after completing at least 6 months of initial anticoagulation therapy.